🇺🇸 Other atypical antipsychotic drugs in United States

Other atypical antipsychotic drugs (Other atypical antipsychotic drugs) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Other atypical antipsychotic drugs in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Other atypical antipsychotic drugs approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Other atypical antipsychotic drugs in United States?

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. is the originator. The local marketing authorisation holder may differ — check the official source linked above.